Tea consumption and Papillary Thyroid Cancer Risk: a Case-Control Study of Adults in Shanghai, China

Author:

Xu Xiaoli1,Zang Jiajie2,Wang Zhengyuan2,Wang Jiadong3,Wu Yi4,Liu Meixia2,Shi Zehuan2,Song Qi2,Cui Xueying2,Wu Fan5

Affiliation:

1. Shanghai Minhang District Center for Disease Control and Prevention

2. Shanghai Municipal Center for Disease Control and Prevention

3. Shanghai Jiao Tong University

4. Shanghai Tumor Hospital

5. Shanghai Institutes of Preventive Medicine

Abstract

Abstract Few studies have explored the impact of consumption of three types of tea on the risk for papillary thyroid cancer (PTC) in East Asia. A case-control study was conducted with323 Chinese patients with histological confirmed differentiated thyroid cancer and 323 healthy subjects selected from the same hospital. Participants were matched by age, nationality and gender, and interviewed face-to-face by trained interviewers using a structured questionnaire. Participants who drank tea at least once a day (p = 0.023) or consumed ≤ five grams each time (p = 0.047) had a lower PTC risk than unfermented tea non-drinkers had. Participants who drank tea at least once a month but < once a day (p = 0.023) or consumed ≤ five grams each time (p = 0.018) had a lower PTC risk than did semi-fermented tea non-drinkers. Among females, a significantly lower PTC risk was found in those who drank unfermented tea at least once a day (p = 0.030) compared with the unfermented tea non-drinkers. No dose-response relationship of the ever-drinkers’ three tea types was found between the amount of tea consumed each time and a lower PTC risk among all participants. Consuming unfermented tea at least once a day was the most protective factor in lowering PTC risk among females.

Publisher

Research Square Platform LLC

Reference29 articles.

1. Geographic influences in the global rise of thyroid cancer;Kim J;Nature reviews. Endocrinology 2020

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F;CA: a cancer journal for clinicians,2018

3. Thyroid cancer;Cabanillas ME;Lancet,2016

4. Global Burden of Thyroid Cancer From 1990 to 2017;Deng Y;JAMA network open,2020

5. Thyroid cancer: incidence and mortality trends in China, 2005–2015;Wang J;Endocrine 2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3